Physician profile
Griffith R Batstone
NPI 1508049487
$122,829.30
in general payments reported to CMS, 2019-2025
32 companies · $58K in 2025
The $58K reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38K · 2020: $11K · 2021: $11K · 2022: $122 · 2023: $338 · 2024: $4,548 · 2025: $58K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $41K · Honoraria: $16K · Travel and Lodging: $3,476 · Food and Beverage: $2,557 · Education: $21.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $40,635.00 |
| Honoraria | $16,399.94 |
| Travel and Lodging | $3,476.30 |
| Food and Beverage | $2,556.85 |
| Education | $21.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $45,221.64 | 2019-2025 | Lumenis Pulse 120h, General - Bph, General - Kidney Stone Disease |
| Lumenis, INC | $30,159.33 | 2019-2021 | |
| Richard Wolf Medical Instruments Corp. | $22,924.76 | 2021-2025 | |
| Olympus America INC. | $22,279.09 | 2019-2025 | Uretero-Reno Videoscope |
| Abbvie INC. | $318.76 | 2019-2025 | Botox |
| Koelis INC. | $282.93 | 2024 | |
| Janssen Biotech, INC. | $241.56 | 2019-2025 | Erleada, Akeega |
| Astellas Pharma US INC | $204.74 | 2019-2024 | Xtandi |
| Procept Biorobotics Corporation | $165.32 | 2023 | Aquabeam Robotic System |
| Coloplast Corp | $85.79 | 2020-2024 | |
| Laborie Medical Technologies Corp. | $79.86 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Bayer Healthcare Pharmaceuticals INC. | $79.83 | 2023-2025 | |
| Teleflex LLC | $79.36 | 2023 | Urolift |
| Sumitomo Pharma America, INC. | $75.57 | 2024-2025 | Gemtesa, Orgovyx |
| Pfizer INC. | $72.84 | 2019-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $55.61 | 2023-2025 | |
| Myriad Genetic Laboratories, INC. | $54.33 | 2021-2022 | |
| Urogen Pharma, INC. | $51.03 | 2025 | |
| Profound Medical Corp. | $43.10 | 2025 | Tulsa-Pro |
| Calyxo, INC. | $40.30 | 2025 | Cvac Aspiration System |
| Philips North America LLC | $38.70 | 2025 | Disease Management Solutions Equipment Undivided |
| C. R. Bard, INC. & Subsidiaries | $34.78 | 2020 | |
| Progenics Pharmaceuticals, INC. | $30.35 | 2025 | |
| Emd Serono, INC. | $29.86 | 2025 | |
| Astrazeneca Pharmaceuticals Lp | $29.30 | 2021 | |
| Myovant Sciences INC. | $26.87 | 2021 | |
| Merck Sharp & Dohme LLC | $26.66 | 2025 | Keytruda, Keytruda Qlex |
| Sun Pharmaceutical Industries INC. | $25.33 | 2025 | |
| Photocure INC | $23.97 | 2020 | |
| Urovant Sciences INC | $18.23 | 2022 | |
| Ferring Pharmaceuticals INC. | $15.23 | 2024 | Adstiladrin |
| Allergan, INC. | $14.27 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Griffith Batstone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.